{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:02:34Z","timestamp":1784257354925,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1245\/s10434-025-19059-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:58:54Z","timestamp":1772477934000},"page":"5293-5303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"33","author":[{"given":"Vladislav","family":"Kovalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeerah","family":"Wasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Iugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniia","family":"Uzhegova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Diaz","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"13","key":"19059_CR1","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1245\/s10434-020-08583-7","volume":"27","author":"PB Schwartz","year":"2020","unstructured":"Schwartz PB, Stahl CC, VandeWalle KA, et al. What drives high costs of cytoreductive surgery and HIPEC: patient, provider or tumor? Ann Surg Oncol. 2020;27(13):4920\u20138. https:\/\/doi.org\/10.1245\/s10434-020-08583-7.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"19059_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist. 2013;18(4):381\u201390. https:\/\/doi.org\/10.1634\/theoncologist.2012-0279.","journal-title":"Oncologist."},{"issue":"2","key":"19059_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JOP.2014.001542","volume":"11","author":"SY Zafar","year":"2015","unstructured":"Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145\u201350. https:\/\/doi.org\/10.1200\/JOP.2014.001542.","journal-title":"J Oncol Pract."},{"key":"19059_CR4","unstructured":"World Health Organization. Economic Evaluation and Analysis (EEA) Team. Distribution of Health Payments and Catastrophic Expenditures Methodology. EIP\/FER\/DP.05.2.; 2005."},{"key":"19059_CR5","doi-asserted-by":"publisher","unstructured":"Ciftci Y, Radomski SN, Johnston FM, Greer JB. Predictors of financial toxicity risk among patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS\u2013HIPEC). Ann Surg Oncol. Published online 4 December 2023. https:\/\/doi.org\/10.1245\/s10434-023-14577-y","DOI":"10.1245\/s10434-023-14577-y"},{"issue":"3","key":"19059_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA De Souza","year":"2017","unstructured":"De Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476\u201384. https:\/\/doi.org\/10.1002\/cncr.30369.","journal-title":"Cancer."},{"issue":"20","key":"19059_CR7","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA de Souza","year":"2014","unstructured":"de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20):3245\u201353. https:\/\/doi.org\/10.1002\/cncr.28814.","journal-title":"Cancer."},{"issue":"1","key":"19059_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50844","volume":"7","author":"S Kircher","year":"2024","unstructured":"Kircher S, Duan F, An N, et al. Patient-reported financial burden of treatment for colon or rectal cancer. JAMA Netw Open. 2024;7(1):e2350844. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50844.","journal-title":"JAMA Netw Open."},{"issue":"3","key":"19059_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139. https:\/\/doi.org\/10.1200\/JCO.1993.11.3.570.","journal-title":"J Clin Oncol."},{"issue":"6","key":"19059_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ijgc-2021-002475","volume":"31","author":"KM Esselen","year":"2021","unstructured":"Esselen KM, Gompers A, Hacker MR, et al. Evaluating meaningful levels of financial toxicity in gynecologic cancers. Int J Gynecol Cancer. 2021;31(6):801\u20136. https:\/\/doi.org\/10.1136\/ijgc-2021-002475.","journal-title":"Int J Gynecol Cancer."},{"issue":"15","key":"19059_CR11","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1200\/JCO.2017.35.15_suppl.6615","volume":"35","author":"JA De Souza","year":"2017","unstructured":"De Souza JA, Wroblewski K, Proussaloglou E, Nicholson L, Hantel A, Wang Y. Validation of a financial toxicity (FT) grading system. J Clin Oncol. 2017;35(15):6615\u20136615. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.6615.","journal-title":"J Clin Oncol."},{"issue":"3","key":"19059_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61(3):347\u201354. https:\/\/doi.org\/10.1097\/DCR.0000000000001003.","journal-title":"Dis Colon Rectum."},{"key":"19059_CR13","doi-asserted-by":"publisher","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Vol 82. Cancer Treatment and Research. Springer US; 1996:359-374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"7","key":"19059_CR14","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/s002800051093","volume":"43","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol. 1999;43(7):S15\u201325. https:\/\/doi.org\/10.1007\/s002800051093.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"2","key":"19059_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"4","key":"19059_CR16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jso.26371","volume":"123","author":"A Nikiforchin","year":"2021","unstructured":"Nikiforchin A, Gushchin V, King MC, et al. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 2021;123(4):1030\u201344. https:\/\/doi.org\/10.1002\/jso.26371.","journal-title":"J Surg Oncol."},{"key":"19059_CR17","unstructured":"Dancey CP, Reidy J. Statistics without maths for psychology. Pearson\/Prentice Hall; 2007. https:\/\/books.google.com\/books?id=QjfQ0_DqyNQC"},{"issue":"1","key":"19059_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1200\/OP.24.00162","volume":"21","author":"FJ Hlubocky","year":"2025","unstructured":"Hlubocky FJ, Cella D, Daugherty CK. Financial toxicity has never been more important in cancer care: how do we measure it? JCO Oncol Pract. 2025;21(1):52\u20136. https:\/\/doi.org\/10.1200\/OP.24.00162.","journal-title":"JCO Oncol Pract."},{"issue":"9378","key":"19059_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0140-6736(03)13861-5","volume":"362","author":"K Xu","year":"2003","unstructured":"Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. Household catastrophic health expenditure: a multicountry analysis. Lancet Lond Engl. 2003;362(9378):111\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(03)13861-5.","journal-title":"Lancet Lond Engl."},{"issue":"6","key":"19059_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/ijgc-2023-005054","volume":"34","author":"AJ Smith","year":"2024","unstructured":"Smith AJ, Sharma MH, Powell K, Doherty M, Hinkle SN, Ko EM. Financial toxicity in gynecologic oncology: a multi-practice survey. Int J Gynecol Cancer. 2024;34(6):919\u201325. https:\/\/doi.org\/10.1136\/ijgc-2023-005054.","journal-title":"Int J Gynecol Cancer."},{"issue":"8","key":"19059_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.6004\/jnccn.2024.7030","volume":"22","author":"SB Wheeler","year":"2024","unstructured":"Wheeler SB, Manning ML, Gellin M, et al. Impact of a comprehensive financial navigation intervention to reduce cancer-related financial toxicity. J Natl Compr Canc Netw. 2024;22(8):557\u201362. https:\/\/doi.org\/10.6004\/jnccn.2024.7030.","journal-title":"J Natl Compr Canc Netw."},{"issue":"1","key":"19059_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1377\/hlthaff.2015.0830","volume":"35","author":"MP Banegas","year":"2016","unstructured":"Banegas MP, Guy GP, De Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54\u201361. https:\/\/doi.org\/10.1377\/hlthaff.2015.0830.","journal-title":"Health Aff (Millwood)."},{"issue":"4","key":"19059_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cllc.2018.12.010","volume":"20","author":"DA Ezeife","year":"2019","unstructured":"Ezeife DA, Morganstein BJ, Lau S, et al. Financial burden among patients with lung cancer in a publically funded health care system. Clin Lung Cancer. 2019;20(4):231\u20136. https:\/\/doi.org\/10.1016\/j.cllc.2018.12.010.","journal-title":"Clin Lung Cancer."},{"issue":"10","key":"19059_CR24","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","volume":"2","author":"SF Huntington","year":"2015","unstructured":"Huntington SF, Weiss BM, Vogl DT, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2(10):e408\u201316. https:\/\/doi.org\/10.1016\/S2352-3026(15)00151-9.","journal-title":"Lancet Haematol."},{"issue":"20","key":"19059_CR25","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1200\/JCO.2010.33.0522","volume":"29","author":"DSM Bernard","year":"2011","unstructured":"Bernard DSM, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821\u20136. https:\/\/doi.org\/10.1200\/JCO.2010.33.0522.","journal-title":"J Clin Oncol."},{"issue":"11","key":"19059_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jamaoncol.2017.2148","volume":"3","author":"F Chino","year":"2017","unstructured":"Chino F, Peppercorn JM, Rushing C, et al. Out-of-pocket costs, financial distress, and underinsurance in cancer care. JAMA Oncol. 2017;3(11):1582. https:\/\/doi.org\/10.1001\/jamaoncol.2017.2148.","journal-title":"JAMA Oncol."},{"issue":"19","key":"19059_CR27","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1002\/cncr.28812","volume":"120","author":"SE Regenbogen","year":"2014","unstructured":"Regenbogen SE, Veenstra CM, Hawley ST, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014;120(19):3074\u201381. https:\/\/doi.org\/10.1002\/cncr.28812.","journal-title":"Cancer."},{"key":"19059_CR28","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Ovarian Cancer, Including Fallopian Tube Cancer and Primary Peritoneal Cancer, V.1.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed on May 7, 2025."},{"issue":"23","key":"19059_CR29","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1200\/JCO.19.00594","volume":"37","author":"SN Koole","year":"2019","unstructured":"Koole SN, Van Lieshout C, Van Driel WJ, et al. Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial. J Clin Oncol. 2019;37(23):2041\u201350. https:\/\/doi.org\/10.1200\/JCO.19.00594.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19059-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:55Z","timestamp":1778869675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19059-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19059"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19059-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial discloses or conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}